Skip to content
thestock.space

Epigral (EPIGRAL) had a P/E of 13.8× on 6 Nov 2026, below the industry P/E of 18.2×, and the shares are 45% below their 52-week high. It earns ROCE of 14% and ROE of 13%, and sales grew 4.8% a year over 3 years while net profit fell 2.1%. Its dividend yield is 0.6%, and debt is 0.24× equity. It is a small-cap company with a market cap of ₹3,940 Cr, ranked 11th of 76 Chemicals companies by market cap; the shares fell 44% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹936.90
Day high
₹936.90
Day low
₹889.30
Prev. close
₹943.95
Volume
54K

Health check

2 good · 2 fair · 2 to check
  • ReturnsBehind

    −43.9% over a year, better than 0 of 7 peers.

  • Price tagCheaper

    P/E 13.8 vs industry 18.2.

  • GrowthStrong

    Sales +4.8%, profit −2.1% a year over 3 years.

  • ProfitabilityAverage

    ROCE 13.9% vs peer median 10.6%.

  • Balance sheetFair

    Debt 0.24× equity, interest covered 8.3×, Piotroski 5 of 9.

  • Red flags1 to check

    45% below its 52-week high.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Chemicals

75 listed peers. Screen the industry

Small cap

₹3,940 Cr, #11 of 76 in its industry by size.

Defensive

Beta 0.30 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹2,785 Cr · profit ₹285 Cr
Market cap
₹3,940 Cr
Small cap
P/E
13.8
Industry 18.2
Price to book
1.67
Peers 2.62
Dividend yield
0.55%
ROE
12.8%
Peers 11.7%
ROCE
13.9%
Peers 10.6%
Debt to equity
0.24
Debt ₹570 Cr
EPS (TTM)
₹66.03
Face value ₹10
OPM (TTM)
21.1%
Net margin 10.2%
Sales growth
+27.0%
Latest quarter vs a year ago
Profit growth
+27.1%
Latest quarter vs a year ago
Price to sales
1.41
EV/EBITDA 7.8

Strengths and risks

Strengths

  • Quarterly profit up 27.1% on a year ago.
  • Quarterly sales up 27.0% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • 45% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Epigral

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings,…

Headquarters
Ahmedabad
Employees
1,135
Sector
Basic Materials
ISIN
INE071N01016
Website
epigral.com

Price range

52 weeks

₹807.00₹1,669.40

Today

₹889.30₹936.90
Avg volume (3M)
58.3K
1-year return
minus 43.9%
From 52-week high
minus 45.3%

Peers · Chemicals

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
NAVINFLUORNavin Fluorine International9,010.00plus 1.87%46,25050.842.718.7%34.3%0.2816.5%plus 46.1%
DEEPAKNTRDeepak Nitrite1,533.60minus 0.67%20,91719.722.310.8%18.0%0.27−0.5%minus 11.9%
TATACHEMTata Chemicals607.45minus 1.36%15,475–12.4−3.0%12.2%0.36−4.8%minus 31.0%
DEEPAKFERTDeepak Fertilisers & Petrochemicals Corp.1,155.30minus 0.69%14,59914.811.511.2%17.6%0.762.6%minus 22.7%
RPELRaghav Productivity Enhancers1,780.80plus 0.95%8,178116.0107.1–29.9%0.0223.5%plus 95.4%
GNFCGujarat Narmada Valley Fertilizers and Chemicals451.80minus 1.87%6,6396.35.410.4%14.8%0.01−8.8%minus 7.2%
ACIArchean Chemical Industries416.40minus 1.95%5,14151.323.27.7%20.0%0.28−9.2%minus 34.6%
EPIGRALEpigral913.20minus 3.26%3,94013.87.913.9%22.2%0.244.8%minus 43.9%
Median of 7 peers–−0.69%14,59935.222.310.6%18.0%0.28−0.5%−11.9%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
587597736705746
455494568526610
132103169179136
22.5%17.2%22.9%25.4%18.2%
1.45.5−1.64.76.5
21.81115.87.210.8
42.342.841.742.944.2
69.754.611013487.6
26.5%28.3%26.1%25.4%25.7%
51.239.18199.765.1
11.879.0718.7622.9915.09

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+4.8%
Profit CAGR 3Y
−2.1%
EPS CAGR 3Y
−3.3%
ROE
12.8%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
2,1691,8942,5142,495
–minus 12.7%+32.8%minus 0.8%
1,4801,4131,8041,927
689481711568
31.8%25.4%28.3%22.8%
−10−1.24.41
49.862.342.546.7
109124133168
2.2−3.41−13.4
522291541341
32.4%32.6%33.9%2.6%
353196358332
–minus 44.6%+82.6%minus 7.2%
85.0347.1484.6876.95

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
41.641.643.143.1
1,0281,2131,8612,178
769909593572
594631655712
2,4322,7943,1523,505
1,9522,2352,3112,567
17449092465
00–2.1
14.23.296.56.4
29266.7653465
2,4322,7943,1523,505

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
626398441436
−437−401−262−355
−200−7.6−164−94.5
−10.8−11.115.5−13.6
−416−398−195−394
210−0.824641.4
−24.2−25.1−41.9−18.3

Shareholding pattern

Source: NSE filings
68.8%
promoters
  • Promoters68.83%
  • Public31.17%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202668.83%31.17%0.00
30 Jun 202668.83%31.17%0.00
31 Mar 202668.83%31.17%0.00
31 Dec 202568.83%31.17%0.00
30 Sep 202568.83%31.17%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you